PROCEPT BioRobotics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Public

  • Employees
  • 888

Employees

  • Stock Symbol
  • PRCT

Stock Symbol

  • Share Price
  • $23.82
  • (As of Friday Closing)

PROCEPT BioRobotics General Information

Description

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Contact Information

Formerly Known As
Procept
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 900 Island Drive
  • Suite 170
  • Redwood Shore, CA 94065
  • United States
+1 (650)
Primary Industry
Surgical Devices
Other Industries
Diagnostic Equipment
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 900 Island Drive
  • Suite 170
  • Redwood Shore, CA 94065
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PROCEPT BioRobotics Stock Performance

As of 13-Nov-2026, PROCEPT BioRobotics’s stock price is $23.82. Its current market cap is $1.37B with 57.5M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$23.82 $23.51 $16.66 - $38.11 $1.37B 57.5M 1.26M -$2.02

PROCEPT BioRobotics Financials Summary

As of 30-Sep-2026, PROCEPT BioRobotics has a trailing 12-month revenue of $352M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 893,112 1,542,585 4,240,512 1,909,049
Revenue 352,305 308,054 224,498 136,191
EBITDA (110,596) (97,625) (92,522) (105,566)
Net Income (114,860) (95,572) (91,413) (105,897)
Total Assets 473,759 508,081 534,017 404,717
Total Debt 76,992 78,483 80,250 79,204
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PROCEPT BioRobotics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PROCEPT BioRobotics‘s full profile, request access.

Request a free trial

PROCEPT BioRobotics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore PROCEPT BioRobotics‘s full profile, request access.

Request a free trial

PROCEPT BioRobotics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative s
Surgical Devices
Redwood Shore, CA
888 As of 2025

Boulder, CO
 

Abbot Park, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PROCEPT BioRobotics Competitors (14)

One of PROCEPT BioRobotics’s 14 competitors is Encision, a Corporation company based in Boulder, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Encision Corporation Boulder, CO
Abbott Corporation Abbot Park, IL
Medtronic Corporation Minneapolis, MN
CooperSurgical Corporate Backed or Acquired Trumbull, CT
Stryker Formerly VC-backed Portage, MI
You’re viewing 5 of 14 competitors. Get the full list »

PROCEPT BioRobotics Patents

PROCEPT BioRobotics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260289771-A1 Conformal treatment planning using three-dimensional ultrasound Pending 18-Mar-2025
WO-2026198472-A1 Conformal treatment planning using three-dimensional ultrasound Pending 18-Mar-2025
US-20260283696-A1 Three-dimensional reconstruction of anatomical region using three-dimensional ultrasound Pending 18-Mar-2025
EP-4832841-A1 Image guided cancer treatment system and methods Pending 29-Dec-2023
US-20250221774-A1 Image guided cancer treatment system and methods Pending 29-Dec-2023 G16H20/40
To view PROCEPT BioRobotics’s complete patent history, request access »

PROCEPT BioRobotics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PROCEPT BioRobotics ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

27.98 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view PROCEPT BioRobotics’s complete esg history, request access »

PROCEPT BioRobotics FAQs

  • When was PROCEPT BioRobotics founded?

    PROCEPT BioRobotics was founded in 2009.

  • Where is PROCEPT BioRobotics headquartered?

    PROCEPT BioRobotics is headquartered in Redwood Shore, CA.

  • What is the size of PROCEPT BioRobotics?

    PROCEPT BioRobotics has 888 total employees.

  • What industry is PROCEPT BioRobotics in?

    PROCEPT BioRobotics’s primary industry is Surgical Devices.

  • Is PROCEPT BioRobotics a private or public company?

    PROCEPT BioRobotics is a Public company.

  • What is PROCEPT BioRobotics’s stock symbol?

    The ticker symbol for PROCEPT BioRobotics is PRCT.

  • What is the current stock price of PROCEPT BioRobotics?

    As of 13-Nov-2026 the stock price of PROCEPT BioRobotics is $23.82.

  • What is the current market cap of PROCEPT BioRobotics?

    The current market capitalization of PROCEPT BioRobotics is $1.37B.

  • What is PROCEPT BioRobotics’s current revenue?

    The trailing twelve month revenue for PROCEPT BioRobotics is $352M.

  • Who are PROCEPT BioRobotics’s competitors?

    Encision, Abbott, Medtronic, CooperSurgical, and Stryker are some of the 14 competitors of PROCEPT BioRobotics.

  • What is PROCEPT BioRobotics’s annual earnings per share (EPS)?

    PROCEPT BioRobotics’s EPS for 12 months was -$2.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process